Publication | Closed Access
Inhibition of Development of Sarcoma 180 by 4-Amino-N10-Methyl Pteroylglutamic Acid.
29
Citations
0
References
1949
Year
Medicinal ChemistryRadiation OncologyOncogenic AgentMedicineSarcoma 180PharmacotherapyAnti-cancer AgentMetronomic ChemotherapyBiomolecular EngineeringPharmacologyCell TransplantationTumor BiologyDrug ToxicityFew MiceHealth Sciences
The compound 4-Amino-N10-methyl pteroylglutamic acid, has shown the ability to inhibit the growth of the transplantable mouse Sarcoma 180 when administered intraperitoneally in concentrations of 1.5 mg/kg each day for 7 days. At this dosage very few mice died from drug toxicity. The inhibition is most apparent when the compound is administered early in the development of the tumor.